Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by Upregulating SOCS-1 Expression
Conclusions.
AXL activation protects the liver from I/R injury by upregulating SOCS-1 and inhibiting the toll-like receptor 4/myeloid differentiation factor-88/nuclear factor kappa-B signaling axis. Targeting AXL may be a new therapeutic option for ameliorating hepatic I/R injury.
Source: Transplantation - Category: Transplant Surgery Tags: Original Basic Science—General Source Type: research
More News: Adenoviruses | Liver | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology